Company profile
Revium Rx. CIK 1839140
Ticker
RVRC (OTC)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10151
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$13.45M
Total assets
$8.30M
Total liabilities
$1.42M
Stockholders' equity
$6.88M
Cash & equivalents
$1.68M
Operating income
—
Operating cash flow
—
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
17.1%
Equity / assets
82.9%
CapEx / revenue
—
Operating cash flow / net income
—
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$13.45M
$8.30M
$1.42M
$6.88M
2024
—
—
$20.28M
$576.0K
$19.71M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-31
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
New York, NY 10151
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:45 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.